Lymphoma, T-Cell

specific

A malignant lymphoid neoplasm composed of EBV-positive NK/T cells arranged in an angiocentric pattern.

30

Centers

41

Active Trials

Cancer Funding

Top Centers for Lymphoma, T-Cell(30)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
73.4
2
NCI Comprehensive
High-Volume Research Center
70.4
3
NCI Comprehensive
High-Volume Research Center
70.4
4
High-Volume Research Center
70.4
5
NCI Comprehensive
Active Research Program
62.9
6
NCI Comprehensive
Active Research Program
62.9
7
NCI Comprehensive
Active Research Program
62.9
8
NCI Comprehensive
Active Research Program
62.9
9
Active Research Program
62.9
10
Active Research Program
62.9
11
Active Research Program
62.9
12
NCI Comprehensive
Active Research Program
47.9
13
NCI Comprehensive
Active Research Program
47.9
14
NCI Comprehensive
Active Research Program
47.9
15
NCI Comprehensive
Active Research Program
47.9
16
NCI Comprehensive
Active Research Program
47.9
1747.9
18
NCI Comprehensive
Active Research Program
47.9
19
NCI Comprehensive
Active Research Program
47.9
20
NCI Clinical
Active Research Program
47.9
21
Active Research Program
47.9
22
Active Research Program
47.9
23
NCI Comprehensive
Active Research Program
47.9
24
Active Research Program
47.9
2533.7
26
NCI Comprehensive
33.7
27
NCI Comprehensive
33.7
28
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
33.7
29
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
33.7
30
BC CancerVancouver, BC
33.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →